Filing Details
- Accession Number:
- 0001144204-14-066837
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-12 08:01:06
- Reporting Period:
- 2014-11-10
- Filing Date:
- 2014-11-12
- Accepted Time:
- 2014-11-12 08:01:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1369868 | China Biologic Products Inc. | CBPO | Biological Products, (No Disgnostic Substances) (2836) | 752308816 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1432657 | Sean Shao | 21St Floor, Everbright Bank Building Zhuzilin, Futian District Shenzhen, Guangdong F4 100125 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-10 | 40,000 | $12.26 | 62,500 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-11-10 | 30,000 | $16.39 | 92,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-10 | 40,000 | $62.75 | 52,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-10 | 30,000 | $62.75 | 22,500 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-11-10 | 2,500 | $62.75 | 20,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-10 | 40,000 | $0.00 | 40,000 | $12.26 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-10 | 30,000 | $0.00 | 30,000 | $16.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 30,000 | 2010-10-11 | 2020-07-11 | No | 4 | M | Direct |
| 0 | 2011-04-01 | 2021-01-01 | No | 4 | M | Direct |
Footnotes
- Represents an aggregate of 70,000 shares of common stock (the "Sold Common Stock") sold on the open market for $62.75 per share on November 10, 2014. The Sold Common Stock was acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnotes 2 and 3 below for further details on the relevant stock options.
- Represents previously reported stock options to purchase 40,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated July 11, 2010. The options will vest in equal portions on a quarterly basis over a 3-year period, with the first portion to vest on October 11, 2010.
- Represents previously reported stock options to purchase 30,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's equity incentive plan, pursuant to a stock option agreement, dated January 1, 2011. The options will vest in equal portions on a quarterly basis over a 12-month period, with the first portion to vest on April 1, 2011.
Billionaire Hedge Funds
